SK284802B6 - Deriváty N-triazolylmetylpiperazínu s antagonistickou aktivitou k neurokinínovým receptorom, spôsob ich výroby, medziprodukt a liečivá s ich obsahom - Google Patents

Deriváty N-triazolylmetylpiperazínu s antagonistickou aktivitou k neurokinínovým receptorom, spôsob ich výroby, medziprodukt a liečivá s ich obsahom Download PDF

Info

Publication number
SK284802B6
SK284802B6 SK757-2001A SK7572001A SK284802B6 SK 284802 B6 SK284802 B6 SK 284802B6 SK 7572001 A SK7572001 A SK 7572001A SK 284802 B6 SK284802 B6 SK 284802B6
Authority
SK
Slovakia
Prior art keywords
alkyl
ring
nitrogen
optionally substituted
atoms
Prior art date
Application number
SK757-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK7572001A3 (en
Inventor
Daniel Jasserand
Uwe Sch�N
Holger Sann
Reinhard Br�Ckner
Christian Eeckhout
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of SK7572001A3 publication Critical patent/SK7572001A3/sk
Publication of SK284802B6 publication Critical patent/SK284802B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK757-2001A 2000-07-28 2001-06-01 Deriváty N-triazolylmetylpiperazínu s antagonistickou aktivitou k neurokinínovým receptorom, spôsob ich výroby, medziprodukt a liečivá s ich obsahom SK284802B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10036818A DE10036818A1 (de) 2000-07-28 2000-07-28 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten

Publications (2)

Publication Number Publication Date
SK7572001A3 SK7572001A3 (en) 2002-02-05
SK284802B6 true SK284802B6 (sk) 2005-11-03

Family

ID=7650544

Family Applications (1)

Application Number Title Priority Date Filing Date
SK757-2001A SK284802B6 (sk) 2000-07-28 2001-06-01 Deriváty N-triazolylmetylpiperazínu s antagonistickou aktivitou k neurokinínovým receptorom, spôsob ich výroby, medziprodukt a liečivá s ich obsahom

Country Status (28)

Country Link
US (1) US6407106B1 (da)
EP (1) EP1176144B1 (da)
JP (1) JP2002053577A (da)
KR (1) KR100924405B1 (da)
CN (1) CN1167698C (da)
AR (1) AR028743A1 (da)
AT (1) ATE244716T1 (da)
AU (1) AU779318B2 (da)
BR (1) BR0103048A (da)
CA (1) CA2354213C (da)
CZ (1) CZ301695B6 (da)
DE (2) DE10036818A1 (da)
DK (1) DK1176144T3 (da)
DZ (1) DZ3119A1 (da)
ES (1) ES2201007T3 (da)
HK (1) HK1042699A1 (da)
HU (1) HU226687B1 (da)
IL (1) IL144299A (da)
IN (1) IN191021B (da)
NO (1) NO323233B1 (da)
NZ (1) NZ513041A (da)
PL (1) PL210436B1 (da)
PT (1) PT1176144E (da)
RU (1) RU2288918C2 (da)
SK (1) SK284802B6 (da)
TW (1) TWI304403B (da)
UA (1) UA73728C2 (da)
ZA (1) ZA200105737B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77515C2 (en) * 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
DE60321907D1 (de) * 2002-04-26 2008-08-14 Lilly Co Eli Tachykininrezeptorantagonisten
MY141559A (en) * 2002-04-26 2010-05-14 Lilly Co Eli Triazole derivatives as tachykinin receptor antagonists
WO2005000821A1 (en) * 2003-06-12 2005-01-06 Eli Lilly And Company Tachykinin receptor antagonists
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same
ATE487704T1 (de) * 2005-07-25 2010-11-15 Hoffmann La Roche Substituierte triazolderivate und ihre verwendung als antagonisten des neurokinin-3-rezeptors
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
WO2011020874A1 (en) 2009-08-20 2011-02-24 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
ES2672099T3 (es) 2011-07-04 2018-06-12 Irbm - Science Park S.P.A. Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
AU2019223237A1 (en) 2018-02-26 2020-09-03 Ospedale San Raffaele S.R.L. NK-1 antagonists for use in the treatment of ocular pain
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency
CN115184498B (zh) * 2022-07-15 2023-02-21 山东京卫制药有限公司 N-Boc-哌嗪中有关物质哌嗪的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
US5883098A (en) 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
KR19990021857A (ko) * 1995-05-25 1999-03-25 후지야마 아키라 뉴로키닌 수용체 길항물질로서 1-벤조일-2-(인돌일-3-알킬)-피페라진 유도체
GB9513118D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
CA2240835A1 (en) * 1995-12-18 1997-06-26 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives as tachykinin antagonists
KR100458346B1 (ko) * 1996-03-29 2005-06-21 듀파 인터내셔날 리서치 베 파우 피페라진및피페리딘화합물
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
DE59814233D1 (de) * 1997-08-27 2008-07-03 Solvay Pharm Gmbh Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
DE19824865A1 (de) 1997-08-27 1999-03-04 Solvay Pharm Gmbh Neue Harnstoffderivate
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Also Published As

Publication number Publication date
PT1176144E (pt) 2003-11-28
IN191021B (da) 2003-09-13
DK1176144T3 (da) 2003-10-27
HK1042699A1 (en) 2002-08-23
CA2354213A1 (en) 2002-01-28
IL144299A0 (en) 2002-05-23
HU226687B1 (en) 2009-06-29
DE50100358D1 (de) 2003-08-14
TWI304403B (en) 2008-12-21
HUP0102931A2 (hu) 2002-11-28
US20020065276A1 (en) 2002-05-30
CN1167698C (zh) 2004-09-22
JP2002053577A (ja) 2002-02-19
AU779318B2 (en) 2005-01-13
PL210436B1 (pl) 2012-01-31
AR028743A1 (es) 2003-05-21
ATE244716T1 (de) 2003-07-15
NO20013709D0 (no) 2001-07-27
NO20013709L (no) 2002-01-29
BR0103048A (pt) 2002-04-02
HUP0102931A3 (en) 2003-07-28
UA73728C2 (en) 2005-09-15
DZ3119A1 (fr) 2004-09-19
KR100924405B1 (ko) 2009-10-29
KR20020010482A (ko) 2002-02-04
HU0102931D0 (en) 2001-09-28
US6407106B1 (en) 2002-06-18
CZ20011813A3 (cs) 2002-03-13
IL144299A (en) 2004-08-31
NZ513041A (en) 2002-12-20
RU2288918C2 (ru) 2006-12-10
CN1335316A (zh) 2002-02-13
ZA200105737B (en) 2002-01-22
CA2354213C (en) 2010-04-27
AU5767501A (en) 2002-01-31
EP1176144B1 (de) 2003-07-09
EP1176144A1 (de) 2002-01-30
ES2201007T3 (es) 2004-03-16
PL348946A1 (en) 2002-02-11
NO323233B1 (no) 2007-02-05
DE10036818A1 (de) 2002-02-07
CZ301695B6 (cs) 2010-05-26
SK7572001A3 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
AU769081B2 (en) NPY antagonists: spiroisoquinolinone derivatives
EP1076055B1 (en) 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
DE19952146A1 (de) Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AU709070B2 (en) Novel compounds with platelet aggregation inhibitor activity
CA2853833A1 (en) Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
SK284802B6 (sk) Deriváty N-triazolylmetylpiperazínu s antagonistickou aktivitou k neurokinínovým receptorom, spôsob ich výroby, medziprodukt a liečivá s ich obsahom
CZ20022880A3 (cs) Deriváty chinolinu jako alfa 2 antagonisté
EP0855397B1 (en) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same
US4973592A (en) 1,3-diazocycloalkenes as muscarinic receptor blocking agents
EP0376155A1 (en) N-Pyridinyl-9H-carbazol-9-amines, a process for their preparation and their use as medicaments
JP2001122784A (ja) １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬
JPH10203987A (ja) （ｒ）−１−エチル−４−メチルヘキサヒドロ−１ｈ−１，４−ジアゼピン誘導体を有効成分とするモルヒネ様薬剤誘発嘔吐抑制剤
BG63385B1 (bg) Заместени фениламидини, лекарствени средства, които ги съдържат, и метод за тяхното получаване
JP2990073B2 (ja) （ｒ）−１−エチル−４−メチルヘキサヒドロ−１ｈ−１，４−ジアゼピン誘導体及びそれを含有する医薬
MXPA01007227A (en) N-triazolylmethyl-piperazine derivatives as neurokinine receptor-antagonists
JPS6377874A (ja) キナゾリン誘導体を含有する強心剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120601